Drug Development Solutions

  1. Peptide Development Strategies 10/27/2022

    Peptides occupy a therapeutic niche between small molecules and large biologics. We understand the fundamental physiological challenges to peptide delivery and that there is no “one-size-fits-all” approach for formulation design.

  2. Analytical, Formulation & Stability 2/17/2022

    We have experience with monoclonal antibodies, antibody-drug conjugates, and many other molecule types, including highly glycosylated proteins and biosimilars.

  3. Co-Crystal Prediction Service 11/4/2025

    AI-driven co-crystal prediction accelerates solubility optimization by identifying ideal co-formers in days without needing the drug substance. Learn how to save time, reduce costs, and boost formulation success.

  4. Cell Culture Media For Viral Vector Applications 11/3/2025

    Explore media solutions for viral vector production that support HEK293 and insect cells, with custom development, analytical testing, and scalable preparation tools to optimize performance.

  5. HyClone Cell Boost 1 Supplement 9/21/2020

    Improve productivity and cell growth in fed-batch cultures by supplementing the cell culture medium to boost nutrients depleted during culture. HyClone™ Cell Boost™ 1 Supplement provides nutrients such as amino acids and glucose that are suitable for research and bioprocessing applications.

  6. Stabilizer Brochure 1/13/2025

    Explore stabilizers and buffering agents to enhance protein stability in biologics, preventing aggregation and degradation due to pH, thermal, and mechanical stress in drug formulations.

  7. Accelerating FIH Trials To POC With Speed, Safety, And Certainty 10/15/2025

    Overcome clinical transition challenges with integrated services, including study design, expert regulatory support, robust recruitment, and flexible manufacturing.

  8. High Resolution Mass Spectrometric Analysis Of Complex Biotherapeutics 5/7/2025

    Understand why continued research and collaboration between industry and regulatory bodies are essential to define guidelines that ensure safety and efficacy in this rapidly advancing field.

  9. Streamlining Bioconjugation For ADC Development 10/24/2024

    Unlock the potential of your antibody-drug conjugate development by partnering with our experts in bioconjugation to ensure the efficacy, safety, and scalability of your innovative therapies.

  10. Human ADME Studies: Human Metabolism Data For Regulatory Submission 10/16/2025

    Integrated human ADME studies streamline the process from 14C synthesis to clinical conduct and final reporting to accelerate your drug development program.